This inventor holds 36 USPTO granted patents and 19 published patent applications, plus 9 CIPO patents and 19 EPO patents, primarily in Anti-Viral Compounds. Top assignees: Abbvie Inc., Abbott Laboratories Corporation, Reata Pharmaceuticals, Inc.. Active years: 2002-2018.
Location History:
- Gumee, IL (US) (2015)
- Gurnee, IL (US) (2002 - 2018)
Company Filing History:
22 out of 826 
14 out of 4,186 
1 out of 63 
Years Active: 2002-2018
Areas of Expertise:
Title: Spotlight on Inventor Allan C Krueger
Introduction:
Allan C Krueger, a prolific inventor hailing from Gurnee, Illinois, has made significant contributions to the field of antiviral compounds with a total of 36 patents to his name.
Latest Patents:
Krueger's latest patents focus on the development of anti-viral compounds effective in inhibiting the Hepatitis C virus (HCV) polymerase. These compounds demonstrate promising results in inhibiting the replication of HCV, offering new avenues for the treatment of HCV infections.
Career Highlights:
Throughout his career, Krueger has made substantial strides in the pharmaceutical industry, showcasing his expertise in antiviral research. He has notably lent his talents to renowned companies such as AbbVie Inc. and Abbott Laboratories Corporation, where his innovative work has significantly impacted the field.
Collaborations:
Krueger has collaborated with esteemed professionals in the field, including Rolf Wagner and Todd Warren Rockway. These collaborations have enriched his research endeavors, leading to groundbreaking advancements in antiviral treatments against HCV.
Conclusion:
Allan C Krueger's dedication to antiviral research and his numerous patents reflect his unwavering commitment to innovation in the pharmaceutical sector. His contributions continue to pave the way for novel treatments and therapies in the ongoing battle against viral infections.